Veristat
About Veristat
Veristat is a Healthcare company based in Southborough (United States) founded in 1994, and was acquired by SFL Regulatory Affairs & Scientific Communication in March 2022. Clinical trials and regulatory submissions are supported as a CRO. Veristat has completed 9 acquisitions, including Catalyst Regulatory Services, Certus PV and SFL Regulatory Affairs & Scientific Communication. Its website veristat.com draws about 11 thousand monthly visits. Veristat offers products and services including Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is VERISTAT, LLC. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
Veristat is a clinical research organization (CRO) supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Its clinical development services include biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management for a single study or an entire clinical program. It also provides services in preparation of integrated summary documents and submission-ready CDISC data for regulatory filings. In May 2016, Veristat acquired UK-based CRO Spero Oncology for an undisclosed amount. The company was recognized for the second consecutive year as one of the top 50 fastest-growing private companies in Massachusetts.
- Headquarters Southborough, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website veristat.com
- Social LinkedIn X Facebook YouTube
- Acquired by SFL Regulatory Affairs & Scientific Communication (Mar 2022)
- Legal Name Veristat, Llc
- Latest Funding Round$1.33M (USD), Grant
Dec 2021
- InvestorsEuropean Union
& 2 more
- Investments & AcquisitionsCatalyst Regulatory Services
& 8 more
- Acquired by
Products & Services of Veristat
Veristat offers a comprehensive portfolio of products and services, including Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics.
Provides advice for clinical development and adaptive designs.
Manages submissions, agency meetings, and compliance for trials.
Oversees project management and patient recruitment processes.
Creates reports and documents for regulatory and trial needs.
Handles data management, biostatistics, and monitoring committees.
Apps and channels of Veristat
its YouTube channel Veristat has 208 subscribers and 30 videos.
Videos from Veristat
The most watched videos on Veristat's YouTube channel, Veristat (208 subscribers). Click a video to play it here.
More on Veristat.
Funding Insights of Veristat
- Total Rounds 2
- Last Round Grant — $1.33M
- Investors Count 2
All 2 funding rounds of Veristat with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $1.33M | Grant | – | – | |
| Jan 2013 | Private Equity Round | – | Variance Development Partners | – |
3 investors in total: 3 institutional.
Investors in Veristat
Veristat has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SFL Regulatory Affairs & Scientific Communication and Variance Development Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US private equity investments are managed by Variance Development Partners. | 2012 | variancedp.com | Winnetka, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Consulting services in regulatory affairs and scientific communication are provided. | 2009 | sfl-services.com | Basel, Switzerland |
Investor details for Veristat
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Veristat
69 people are tracked at Veristat (36 in leadership, 3 in board & advisors, 30 in team).
| Name | Role | Group |
|---|---|---|
Joann Eckhoff | Director Account Development | Leadership |
Patrick Flanagan | Chairman And Chief Executive Officer | Leadership |
Stuart Baxter Fcca | Director, Financial Control Europe | Leadership |
Joshua Korth | Chief Financial Officer | Leadership |
Robin Bliss | Vice President, Strategic Consultant | Leadership |
Kevin Keenan | Sr. Director, Business Development | Leadership |
Cindy Henderson | Chief Strategy Officer (cso) | Leadership |
John P. Balser | Founder, President & Chief Statistical Officer | Leadership |
Barbara Balser | Executive Vice President, CSO | Leadership |
Agnes Jankowicz | VP, Pharmacovigilance | Leadership |
Parris Johnson | Senior Business Development Director | Leadership |
Kim Boericke | Chief Operating Officer | Leadership |
y Taylor | Vice President, Global Clinical Operations | Leadership |
Jane Gaviller-Fortune | Director, Quality Assurance And Compliance | Leadership |
Erin Gaffney | Senior Business Development Director | Leadership |
Prasita Koria | Vice President, Global Head Of Project Management | Leadership |
Flavio Beraldo | Project Director | Leadership |
Antonia Hernandez | Sr Business Development Director | Leadership |
Shayesteh Fürst-Ladani | SVP, SFL, Head, SFL Group | Leadership |
Steven Jones | Senior Director, Business Development | Leadership |
49 more people are available in the full profile.
Complete people profiles for Veristat
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veristat
Veristat has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Catalyst Regulatory Services, Certus PV and SFL Regulatory Affairs & Scientific Communication.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Veristat is engaged in providing clinical research and consultancy services. | instat.com | Chatham, United States | 2003 | Oct 2023 | •••• | |
Semiconductor and power electronic devices are manufactured for various sectors. | scinopsis.com | Frejus, France | 2006 | Jun 2023 | •••• | |
Consulting services in regulatory affairs and scientific communication are provided. | sfl-services.com | Basel, Switzerland | 2009 | Mar 2022 | •••• | |
Togel Hongkong lottery results are provided by Toto HK. | ddrmedic.com | Barcelona, Spain | 2013 | Nov 2021 | •••• | |
Major European functional service provider offering services for data management, EDC, and biostatistics | synequanon.com | Diss, United Kingdom | 1996 | Feb 2021 | •••• | |
Pharmacovigilance services are delivered by Certus PV as a CRO. | certuspv.com | Mississauga, Canada | 2014 | Nov 2020 | •••• | |
Drug design, development, and regulatory consulting services are provided. | catalystreg.com | Chelsea, United States | 2012 | Dec 2019 | •••• | |
Clinical trial management services with patient recruitment focus are provided. | topstoneresearch.com | Toronto, Canada | 2012 | Oct 2018 | •••• | |
Clinical operations support is provided for oncology trials. | spero-oncology.com | Bellshill, United Kingdom | 2014 | May 2016 | •••• |
Complete acquisition details for Veristat
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Veristat
13 dated milestones of Veristat across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Veristat is founded.
- Funding First funding round.
- Acquisition Acquires Spero Oncology.
- Acquisition Acquires Topstone Research.
- Acquisition Acquires Catalyst Regulatory Services.
- Acquisition Acquires Certus PV.
- Acquisition Acquires Syne Qua Non.
- Acquisition Acquires Toto HK.
- Funding Latest funding round, Grant, of $1.3M.
- Acquisition Acquires SFL Regulatory Affairs & Scientific Communication.
- Exit Acquired by SFL Regulatory Affairs & Scientific Communication.
- Acquisition Acquires Scinopsis.
- Acquisition Acquires Veristat.
Competitors of Veristat
Veristat has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of Veristat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Veristat
The website of Veristat (veristat.com) receives about 11.2K visits a month and ranks #2,455,321 among all websites worldwide, #3,364 in Biotechnology and Pharmaceuticals.
- Monthly visits11.2K
▲ 26.4% vs previous month
- Unique visitors3.7K
per month
- Global rank#2,455,321
among all websites
- Category rank#3,364
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit1.8
- Average visit42 sec
- DevicesDesktop 33% · Mobile 67%
Websites whose visitors overlap most with Veristat. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 4gclinical.com | 100% | 29.5K | #706,621 | View details | |
| catalystcr.com | 98% | 15.2K | #2,662,456 | View details | |
| ciscrp.org | 97% | #2,147,656 | View details | ||
| lumanity.com | 95% | 28.8K | #1,211,905 | View details | |
| careaccess.com | 91% | 623.1K | #135,039 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Veristat
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Veristat (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Veristat
Complete news archive for Veristat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veristat
Veristat was founded in 1994 and raised its 1st funding round 19 years after it was founded.
Veristat is headquartered in Southborough, United States. It is registered at Southborough, Massachusetts, United States.
Veristat is a clinical research organization (CRO) supporting clinical trials and regulatory submissions for pharmaceutical, biotechnology, and medical device companies. Its clinical development services include biostatistics, statistical programming, medical writing, clinical monitoring, project management and data management for a single study or an entire clinical program. It also provides services in preparation of integrated summary documents and submission-ready CDISC data for regulatory filings. In May 2016, Veristat acquired UK-based CRO Spero Oncology for an undisclosed amount. The company was recognized for the second consecutive year as one of the top 50 fastest-growing private companies in Massachusetts.
Veristat's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Veristat offers Strategic Consulting, Regulatory Affairs, Clinical Operations, Medical Writing, and Biometrics.
Veristat has made 9 acquisitions, including Catalyst Regulatory Services, Certus PV, and SFL Regulatory Affairs & Scientific Communication.
Veristat has 3 investors. Key investors include European Union, SFL Regulatory Affairs & Scientific Communication, and Variance Development Partners.
Veristat operates through Veristat, Llc.
Yes. Veristat was acquired by SFL Regulatory Affairs & Scientific Communication in March 2022.